Biotest, a subsidiary of Grifols, announced that the US FDA granted approval for its plasma protein therapy Yimmugo earlier today (17 June). Yimmugo is an intravenous immunoglobulin therapy developed ...
EQS-News: Biotest successfully meets primary endpoint in phase III trial with Fibrinogen concentrate
Biotest successfully meets primary endpoint in phase III trial with Fibrinogen concentrate 14.02.2024 / 08:30 CET/CEST The issuer is solely responsible for the content of this announcement. PRESS ...
There’s a new owner for Brooklyn Park-based Biotest Laboratories and its 75,560 square-foot lab and manufacturing facility. Biotest, which makes sterilization and testing products for the health care ...
eieich, March 31, 2025: Biotest AG (ISIN DE0005227201, ISIN DE0005227235) has today concluded a delisting agreement with its major shareholder, Grifols, S.A., which holds approximately 97.14 % of the ...
Biotest AG: Biotest accelerates trimodulin development in hospitalized COVID-19 patients with federal funding in the volume of 29 million EUR 23.11.2021 / 15:34 The issuer is solely responsible for ...
Dreieich, 19 September 2025. Biotest AG announces that, after careful consideration, the Management Board has deemed admissible the request received in writing from Grifols S.A. on 1 August 2025 ...
This document is not, and should not be regarded asinvestment advice or a recommendation, regarding any particular investment. As at the date of publication, the author has a long or short position in ...
If you’re eyeing Biotest and wondering whether now is the right moment to buy, hold, or move on, you’re in good company. The stock has been resting at €28.4, and though its short-term moves have been ...
BT-061 in clinical development for the treatment of RA and psoriasis ABBOTT PARK, Ill. and DREIEICH, Germany, June 21, 2011 /PRNewswire/ -- Abbott and Biotest AG today announced a global agreement to ...
BOCA RATON, Fla., Dec. 4 /PRNewswire/ -- Biotest Pharmaceuticals Corporation, a leading developer of immunology biotherapeutic products, today announced that it has completed the acquisition of the ...
Biotest Pharmaceuticals has sold its U.S. therapy business, which includes its Boca Raton headquarters and plasma production center, to ADMA Biologics of Ramsey, N.J. The $40 million deal gives ...
Dreieich, Germany, October 9, 2025. Biotest AG, a specialist in innovative haematology, clinical immunology and intensive care medicine and part of Grifols, a global healthcare company and leading ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results